Biostem U.S., Corporation

CLEARWATER, FL -- (Marketwired) -- 04/08/13 -- Biostem U.S., Corporation (OTCQB: HAIR) (PINKSHEETS: HAIR) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine sciences sector, today reported that it has reinstated its founder, John Satino as CEO, under whose leadership the Company will launch ... read more

CLEARWATER, FL -- (Marketwire) -- 08/28/12 -- Biostem U.S., Corporation (OTCQB: HAIR) (PINKSHEETS: HAIR) (Biostem, The Company), a fully reporting public company in the stem cell regenerative medicine sector, announced today that, in response to overwhelming inquiries from hair clinics around the nation, it has completed preparation to allow ... read more

CLEARWATER, FL -- (Marketwire) -- 08/13/12 -- Biostem U.S., Corporation (OTCQB: HAIR) (PINKSHEETS: HAIR) (Biostem, the Company) is a fully reporting public company in the stem cell regenerative medicine sciences sector. President, John Satino announced today that the Pizarro Hair Restoration Clinic in Orlando, Florida is now equipped and ... read more

CLEARWATER, FL -- (Marketwire) -- 08/07/12 -- Biostem U.S., Corporation (OTCQB: HAIR) (PINKSHEETS: HAIR) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine sciences sector, announced the appointment of Marina Pizarro, M.D. to its Scientific and Medical Board of Advisors (SAMBA). Chief Executive Officer ... read more

CLEARWATER, FL -- (Marketwire) -- 08/02/12 -- Biostem U.S., Corporation, (OTCQB: HAIR) (PINKSHEETS: HAIR) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine sciences sector, Chief Executive Officer Dwight Brunoehler stated, "Dr. Prendergast is a very talented and very active clinical and research surgeon. ... read more

CLEARWATER, FL -- (Marketwire) -- 07/23/12 -- Biostem U.S., Corporation, (OTCQB: HAIR) (PINKSHEETS: HAIR) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine sciences sector, enters into an agreement with Pizarro Hair Restoration Clinics to offer The Biostem Method™ of stem cell hair re-growth ... read more

FT. LAUDERDALE, FL -- (Marketwire) -- 06/05/12 -- Microcap stock analyst, First Microcap Report, announces its coverage of Biostem U.S., Corporation (OTCQB: HAIR) (PINKSHEETS: HAIR) and an initiating report on the company to be distributed to subscribers by June 8, 2012. Biostem U.S., a fully reporting Nevada corporation with ... read more

CLEARWATER, FL -- (Marketwire) -- 06/01/12 -- Biostem U.S., Corporation (OTCQB: HAIR) (PINKSHEETS: HAIR) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine science sector, has made its Scientific and Medical Board of Advisors publications available on the company website, www.biostemus.com. Chief Executive Officer ... read more

CLEARWATER, FL -- (Marketwire) -- 05/29/12 -- Biostem U.S., Corporation, (OTCQB: HAIR) (PINKSHEETS: HAIR) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine sciences sector, today announced that Philip A. Lowry, MD, has been appointed as the Chairman of its Scientific and Medical ... read more

CLEARWATER, FL -- (Marketwire) -- 05/24/12 -- Biostem U.S., Corporation, (OTCQB: HAIR) (PINKSHEETS: HAIR) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine sciences sector, announces a $5,000,000 financing agreement through private placement of stock. CEO, Dwight Brunoehler, announced today that the company has ... read more

CLEARWATER, FL -- (Marketwire) -- 05/21/12 -- Biostem U.S., Corporation, (OTCQB: HAIR) (PINKSHEETS: HAIR) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine sciences sector, today announced that Jeanne Ann Lumadue, MD, PhD, MBA, has been appointed to its Scientific and Medical Board of ... read more

CLEARWATER, FL -- (Marketwire) -- 04/27/12 -- Biostem U.S., Corporation (OTCQB: BOSM) (PINKSHEETS: BOSM) Chief Executive Officer, Dwight Brunoehler announced today that the Board of Directors has authorized a three for one forward split of the company's common stock. The split has already received approval from FINRA and ... read more

CLEARWATER, FL -- (Marketwire) -- 03/12/12 -- Biostem U.S., Corporation (OTCQB: BOSM) (PINKSHEETS: BOSM) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine sciences sector, announced today the addition of cardiothoracic surgeon Thomas W. Prendergast, M.D. to its Scientific and Medical Board of ... read more